Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Global Drugs and Diagnostics for Hematological Disorders Market ProspectsBharatbook.com added a new report on "Drugs and Diagnostics for Hematological Disorders: Global Markets" provide information regarding screening, testing & treatment options for hematological disorders and blood cancer.
By: Bharat Book Bureau This report provides an overview of the current and potential global market for hematological disorders, treatments and testing technologies. The key objective is to present a comprehensive analysis of the current state of hematological disorders and blood cancers, therapy and technology, and utilization of the various therapeutic and diagnostic modalities to prevent and treat these disorders. http://www.bharatbook.com/ The report’s focus is on hematological disorder treatment strategies such as hematological therapeutics and drugs, chemotherapy, radiotherapy and immunotherapy, and other treatment modalities and testing and screening methods. The report also includes an overview on hematological disorders and staging, diagnostic tests and technologies. Important trends in the field of hematological disorders and cancer research, new developments, and sales forecasts by treatment and screening categories from 2012 through 2017 are provided in this report. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the hematological disorders and blood cancer market (http://www.bharatbook.com). This report provides: An overview of the global market for drugs and diagnostics for hematological disorders. Analyses of global market trends, with data from 2010 through 2012, and projections of compound annual growth rates (CAGRs) through 2017. A breakdown of the market by hematological diseases, hematological cancers, and hematological diagnostics. A review of blood cancers, such as various types of leukemia, lymphoma, and myeloma, and their therapies. Delineation of drugs approved by the FDA for hematological disorders. Comprehensive profiles of key companies in the industry. REASONS FOR DOING THIS STUDY This study was conducted to provide detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. There is an increasing need for new and innovative technologies. This industry is experiencing tremendous growth. Many diseases discussed in this report are global issues, and a need exists for newer diagnostic and treatment strategies. Some of these ailments affect children and the elderly. This study looks at most types of diagnostic and treatment strategies for the clinical management of hematological disorders and blood cancers. For more information kindly visit : http://www.bharatbook.com/ Or Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Fax: + 91 22 27812290 Email: Website: Follow us on twitter: https:// Follow us on Linkedin : http://www.linkedin.com/ Our Blog : http://blog.bharatbook.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|